ES2139597T3 - Uso de s-nitrosotioles para la preparacion de un medicamento para la relajacion del musculo liso. - Google Patents

Uso de s-nitrosotioles para la preparacion de un medicamento para la relajacion del musculo liso.

Info

Publication number
ES2139597T3
ES2139597T3 ES92909921T ES92909921T ES2139597T3 ES 2139597 T3 ES2139597 T3 ES 2139597T3 ES 92909921 T ES92909921 T ES 92909921T ES 92909921 T ES92909921 T ES 92909921T ES 2139597 T3 ES2139597 T3 ES 2139597T3
Authority
ES
Spain
Prior art keywords
smooth muscle
nitrosothiols
relaxation
nitrosotiols
medication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92909921T
Other languages
English (en)
Inventor
Jonathan S Stamler
Joseph Loscalzo
Adam Slivka
Daniel Simon
Robert Brown
Jeffrey Drazen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Application granted granted Critical
Publication of ES2139597T3 publication Critical patent/ES2139597T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

LOS S-NITROSOTIOLES EJERCEN UN POTENTE EFECTO RELAJANTE, MEDIADO POR LA CICLASA DE GUANILATOS, EN LOS MUSCULOS TERSOS NO VASCULARES. ENTRE TALES TIPOS DE MUSCULOS TERSOS CABE INCLUIR A LOS DE LAS VIAS RESPIRATORIAS, GASTROINTESTINALES, LA VEJIGA, EL UTERO Y EL CUERPO CAVERNOSO. DE ESTE MODO, LOS S-NITROSOTIOLES SE PUEDEN UTILIZAR PARA EL TRATAMIENTO O PREVENCION DE LOS TRASTORNOS ASOCIADOS A LA RELAJACION DE LOS MUSCULOS, TALES COMO LA OBSTRUCCION DE LAS VIAS RESPIRATORIAS Y OTROS TRASTORNOS RESPIRATORIOS, LA DISFUNCION DE LA VEJIGA, EL PARTO PREMATURO Y LA IMPOTENCIA. ADICIONALMENTE, LOS SNITROSOTIOLES SE PUEDEN UTILIZAR PARA ALIVIAR LA CONTRACCION DE LOS MUSCULOS TERSOS Y LOS ESPASMOS Y FACILITAR ASI LAS PRACTICAS EN LAS QUE SE UTILIZAN INSTRUMENTOS DE DIAGNOSTICO TALES COMO LA ENDOSCOPIA, BRONCOSCOPIA, LAPAROSCOPIA Y CITOSCOPIA.
ES92909921T 1991-03-29 1992-03-30 Uso de s-nitrosotioles para la preparacion de un medicamento para la relajacion del musculo liso. Expired - Lifetime ES2139597T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67669191A 1991-03-29 1991-03-29
US80466591A 1991-12-11 1991-12-11

Publications (1)

Publication Number Publication Date
ES2139597T3 true ES2139597T3 (es) 2000-02-16

Family

ID=27101601

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92909921T Expired - Lifetime ES2139597T3 (es) 1991-03-29 1992-03-30 Uso de s-nitrosotioles para la preparacion de un medicamento para la relajacion del musculo liso.

Country Status (11)

Country Link
EP (1) EP0582631B1 (es)
JP (1) JPH06506222A (es)
AT (1) ATE187064T1 (es)
AU (2) AU1685292A (es)
CA (1) CA2107219C (es)
DE (1) DE69230373T2 (es)
DK (1) DK0582631T3 (es)
ES (1) ES2139597T3 (es)
GR (1) GR3032351T3 (es)
IL (1) IL101406A (es)
WO (1) WO1992017445A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5570683A (en) * 1990-12-05 1996-11-05 The General Hospital Corporation Methods and devices for treating pulmonary vasoconstriction and asthma
DK0560928T3 (da) * 1990-12-05 1997-12-01 Gen Hospital Corp Anordninger til behandling af pulmonal vasokonstriktion og astma
US5536241A (en) * 1990-12-05 1996-07-16 The General Hospital Corporation Methods and devices for relaxing smooth muscle contractions
US5380758A (en) * 1991-03-29 1995-01-10 Brigham And Women's Hospital S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
US5583101A (en) * 1994-07-15 1996-12-10 Harvard College Use of nitrogen oxide species and adducts to inhibit skeletal muscle contraction
US6063407A (en) * 1995-02-16 2000-05-16 The General Hospital Corporation Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
US5823180A (en) * 1995-04-03 1998-10-20 The General Hospital Corporation Methods for treating pulmonary vasoconstriction and asthma
US5612314A (en) * 1995-04-21 1997-03-18 Brigham & Women's Hospital Nitrosylated neuropeptides
US5824669A (en) 1996-03-22 1998-10-20 Nitromed, Inc. Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
US6232434B1 (en) * 1996-08-02 2001-05-15 Duke University Medical Center Polymers for delivering nitric oxide in vivo
US6617355B1 (en) * 1997-05-21 2003-09-09 The University Of Virginia Patent Foundation Treating asthma by preventing and/or accomodating S-nitrosothiol breakdown
US6207855B1 (en) 1998-06-23 2001-03-27 Duke University Medical Center Stable no-delivering compounds
WO2003015605A2 (en) * 2001-08-20 2003-02-27 University Of Virginia Patent Foundation Use of s-nitrosothiol signaling to treat disordered control of breathing
WO2018132371A2 (en) 2017-01-10 2018-07-19 United Therapeutics Corporation Methods and compositions for treating pulmonary hypertension

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US676691A (en) 1901-02-02 1901-06-18 Rudolph Federroll Acetylene-gas generator.
US2328709A (en) * 1940-06-27 1943-09-07 Socony Vacuum Oil Co Inc Method for stabilizing organic thionitrites
US5002964A (en) * 1988-06-15 1991-03-26 Brigham & Women's Hospital S-nitrosocaptopril compounds and the use thereof
US4900719A (en) * 1988-08-05 1990-02-13 The Ohio State University Nitrosothiols as hypotensive agents
DE69008454T2 (de) * 1989-08-07 1994-08-25 Takeda Chemical Industries Ltd Nitrolsothiolderivate, ihre Herstellung und Verwendung.

Also Published As

Publication number Publication date
WO1992017445A2 (en) 1992-10-15
WO1992017445A3 (en) 1992-12-10
EP0582631A4 (en) 1994-07-06
JPH06506222A (ja) 1994-07-14
EP0582631A1 (en) 1994-02-16
AU1685292A (en) 1992-11-02
CA2107219C (en) 2003-09-16
DE69230373T2 (de) 2000-08-24
GR3032351T3 (en) 2000-04-27
AU5459096A (en) 1996-08-01
EP0582631B1 (en) 1999-12-01
AU702429B2 (en) 1999-02-18
IL101406A (en) 1998-02-08
DE69230373D1 (de) 2000-01-05
CA2107219A1 (en) 1992-09-30
ATE187064T1 (de) 1999-12-15
DK0582631T3 (da) 2000-04-25

Similar Documents

Publication Publication Date Title
ES2139597T3 (es) Uso de s-nitrosotioles para la preparacion de un medicamento para la relajacion del musculo liso.
DE3852892D1 (de) Instrument zum aufrechterhalten des innendurchmessers eines tubusförmigen organs sowie katheter mit diesem instrument.
NO20054910L (no) Andedrettsanordning med en innforingsseksjon konfigurert for losbar fastgjoring med et andedrettsinstrument
BR9900737A (pt) Aparelho de fio de orientação de cateter com flexibilidade de localização específica
FR2293906A1 (fr) Speculum vaginal
DE69129302T2 (de) Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
MX9304110A (es) Utilizacion de inhibidores del complemento para la preparacion de un medicamento destinado a la profilaxis y a la terapia de enfermedades intestinales y cutaneas inflamatorias asi como de purpura.
GR3029779T3 (en) Amino-benzofuryl-and thienyl-derivatives.
BRPI0602588A (pt) método de inserir um tubo alimentador
ES2058423T3 (es) Composicion de factor de crecimiento de fibroblastos, resistente a los acidos, para tratar enfermedades ulcerantes del tracto gastrointestinal.
FR2297640A1 (fr) Catheter
HRP20030830A2 (en) Safety shield for medical needles
ES2153842T3 (es) Derivados de 3-oxo-pirido(1,2-a-)bencimidazol-4-carboxilo y de 4-oxo-azepino(1,2-a)bencimidazol-5-carboxilo utiles en el tratamiento de enfermedades del sistema nervioso central.
ES2103825T3 (es) Composiciones farmaceuticas que contienen 5-difluorometoxi-2-(3,4-dimetoxi-2-piridil)-metilsulfinil)bencimidazol y un agente anti-helicobacter para el tratamiento de trastornos gastrointestinales.
UY30959A1 (es) Subtipo de amidas selectivas de diazabicicloalcanos
DE59803227D1 (de) Marker für eine darm-diagnostik und darm-therapie
ES2089157T3 (es) Nuevos derivados de la 20,21-dinoreburnamenina, su procedimiento de preparacion y los nuevos productos intermedios asi obtenidos, su aplicacion como medicamentos y composiciones que los contienen.
IL277024A (en) ", 5"-dimethoxybenzoyl-3'-amino-3'-deoxyadenosine-5'-triphosphates and their pharmaceutical uses
ES1034986Y (es) Aparato para el tratamiento del cuerpo humano.
HK139796A (en) Use of stomatostatin in the manufacture of a medicament for the treatment of rheumatoid arthritis
Salomonson Exaggeration of deep reflexes
ES2044314T3 (es) Equipo de drenaje para el drenaje del ureter.
MX2021003874A (es) Pasador para un dispositivo de inyección y un dispositivo de entrenamiento de inyección.
MX9102181A (es) Iminobenzodiazepina para el tratamiento de desordenes del sueno
Ii et al. A Randomized Single-Blind Trial on the Efficacy of Cooled Plain Lubricant Jelly in Preventing the Pain of Urethral Catheterization as Compared to Plain Lubricant Jelly at Room Temperature

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 582631

Country of ref document: ES